Almeida da Paz, Michelle
Yildiz, Umut
Kim, Minyoung
Campos-Fornés, Víctor
Pinkasz, Marina
Dahlet, Thomas
Noh, Kyung-Min
Taher, Leila
Funding for this research was provided by:
Austrian Science Fund (P33437)
Graz University of Technology
Article History
Received: 21 March 2025
Accepted: 12 January 2026
First Online: 31 January 2026
Declarations
:
: Human induced pluripotent stem cells used in this study were derived from peripheral blood mononuclear cells with institutional review board approval (Stanford University, reference numbers 29904 and 30064) and approved by the EMBL Research Ethics Committee.
: The authors declare no competing interests.